A Hearn - Concepedia

Author

A Hearn

King's College London ORCID

Also Known As

A Hearn, A P Hearn, A. HEARN, A. Hearn, A.P. Hearn, ANDREW HEARN, Andrew Hearn, Andrew P Hearn, Andrew P. Hearn

Publications

973

Citations

H-Index

Concepts

All Affiliations

King's College London Guy's and St Thomas' NHS Foundation Trust Trinity College Dublin St. James's Hospital Asthma UK

About

A Hearn is an author at King's College London specializing in medicine, allergy, and allergy medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	497
2	Allergy	6	6	448
3	Allergy Medicine	6	6	446
4	Arts	1	1	32
5	Clinical Immunology	1	1	44

A Hearn

Publications

756

Citations

H-Index

Page 1

	Year	Citations
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma Joanne Kavanagh, A Hearn, Jaideep Dhariwal, CHEST Journal AsthmaRheumatologyAllergyReal-world EffectivenessAllergy Medicine	2020	243
Hypothalamic–pituitary–adrenal axis function in patients with chronic depression Stuart Watson, Peter Gallagher, D Del-Estal, Psychological Medicine	2002	130
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma A Hearn, Joanne Kavanagh, G d’Ancona, The Journal of Allergy and Clinical Immunology In Practice InflammationAsthmaSevere Eosinophilic AsthmaAllergyAllergy Medicine	2021	63
Benralizumab after sub‐optimal response to mepolizumab in severe eosinophilic asthma Joanne Kavanagh, A Hearn, G d’Ancona, Allergy AsthmaClinical ImmunologyInflammatory Lung DiseaseLung InflammationAllergy Medicine	2020	44
Real-World Effectiveness of Anti–IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization Jaideep Dhariwal, A Hearn, Joanne Kavanagh, The Journal of Allergy and Clinical Immunology In Practice AsthmaAllergyReal-world EffectivenessAllergy MedicineImmunology	2021	40
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis Alexandra M. Nanzer, Jaideep Dhariwal, Joanne Kavanagh, ERJ Open Research	2020	37
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Amr E. Abbas, Fatima Abbas, The Lancet Diabetes & Endocrinology	2023	34
Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma G d’Ancona, Joanne Kavanagh, Jaideep Dhariwal, Allergy AsthmaAllergy MedicineEosinophilic DisorderBenralizumab TherapyJournalism	2021	32
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial Saul N. Faust, Richard Haynes, Christine E. Jones, The Lancet Child & Adolescent Health	2024	31
Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis Alexandra M. Nanzer, Anne-Catherine Maynard-Paquette, Vardah Alam, The Journal of Allergy and Clinical Immunology In Practice RheumatologyAutoimmune DiseaseAllergyVasculitisGranulocyte	2024	26

Page 1